Rigel Announces Conference Call and Webcast to Report First Quarter 2026 Financial Results

Rigel Pharmaceuticals (Nasdaq: RIGL) will report first quarter 2026 financial results after market close on Tuesday, May 5, 2026.

Rhea-AI Summary

Rigel Pharmaceuticals (Nasdaq: RIGL) will report first quarter 2026 financial results after market close on Tuesday, May 5, 2026. Senior management will host a live conference call and webcast at 4:30 p.m. ET to discuss results and business updates.

Dial-in numbers are 877-407-3088 (domestic) and 201-389-0927 (international). The webcast, slides, and a replay will be available from the Investor Relations section of www.rigel.com and archived for 90 days.

Rigel is a biotechnology company focused on therapies for hematologic disorders and cancer, based in South San Francisco.

Argus Apr 28 session

+0.16% close to close Open Argus

Details

News Market Reaction – RIGL

In the Apr 28 session, RIGL gained 0.16%, reflecting a mild positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

Market Context

This announcement schedules the release of Rigel’s first quarter 2026 results for May 5, 2026 and pr...

Analysis

This announcement schedules the release of Rigel’s first quarter 2026 results for May 5, 2026 and provides access details for the conference call and webcast. It does not include new financial or clinical data. Historically, similar earnings-date notices produced only modest stock moves. Investors may focus next on the actual Q1 figures, commentary on the hematology/oncology portfolio, and any updates following recent regulatory and partnership developments.

Key Figures

Earnings release date: May 5, 2026 Conference call time ET: 4:30 p.m. Conference call time PT: 1:30 p.m. +1 more

Earnings release date

May 5, 2026

First quarter 2026 financial results release after market close

Conference call time ET

4:30 p.m.

Earnings conference call start time Eastern Time

Conference call time PT

1:30 p.m.

Earnings conference call start time Pacific Time

Webcast archive duration

90 days

Replay availability on Rigel’s website after the call

Previous Conferences,earnings date Reports

1 past event · Latest: Feb 24

Same Type 1 event

1. Feb 24

   Earnings call scheduling

   24h Move

   +0.7%

   Announced timing and access details for Q4 and full-year 2025 results call.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SOUTH SAN FRANCISCO, Calif., April 28, 2026 /PRNewswire/ -- Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today announced that it will report its first quarter 2026 financial results after market close on Tuesday, May 5, 2026. Rigel senior management will follow the announcement with a live conference call and webcast at 4:30 p.m. Eastern Time (1:30 p.m. Pacific Time) to discuss the financial results and give an update on the business.

Participants can access the live conference call by dialing 877-407-3088 (domestic) or 201-389-0927 (international). The conference call and accompanying slides will also be webcast live and can be accessed from the Investor Relations section of the company's website at www.rigel.com. The webcast will be archived and available for replay for 90 days after the call via the Rigel website.

About Rigel
Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) is a biotechnology company dedicated to discovering, developing and providing novel therapies that significantly improve the lives of patients with hematologic disorders and cancer. Founded in 1996, Rigel is based in South San Francisco, California. For more information on Rigel, the Company's marketed products and pipeline of potential products, visit  www.rigel.com.

Contact for Investors & Media:  
Investors:
Rigel Pharmaceuticals, Inc.
650.624.1232
ir@rigel.com 

Media:
David Rosen
Argot Partners
Phone: 646.461.6387
Email: david.rosen@argotpartners.com 

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/rigel-announces-conference-call-and-webcast-to-report-first-quarter-2026-financial-results-302754902.html

SOURCE Rigel Pharmaceuticals, Inc.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

When will Rigel (RIGL) release Q1 2026 financial results and when is the conference call?

Rigel will release Q1 2026 results after market close on May 5, 2026. According to the company, senior management will host a live conference call and webcast at 4:30 p.m. ET the same day to discuss results and updates.

How can investors access the Rigel (RIGL) May 5, 2026 conference call and webcast?

Investors can join by dialing 877-407-3088 (domestic) or 201-389-0927 (international). According to the company, the event will also be webcast with slides on www.rigel.com in the Investor Relations section.

Will the Rigel (RIGL) Q1 2026 webcast be available for replay and for how long?

Yes. According to the company, the webcast will be archived and available for replay for 90 days after the call. Replay access will be provided via the Rigel Investor Relations website.

What topics will Rigel (RIGL) management cover during the Q1 2026 call on May 5?

Management will discuss the first quarter 2026 financial results and provide an update on business activities. According to the company, the call will include accompanying slides available on the webcast.

Where can I find contact information for Rigel (RIGL) investor and media inquiries ahead of the May 5 call?

Investor inquiries can be directed to rigel at 650-624-1232 and ir@rigel.com; media contact is David Rosen at 646-461-6387. According to the company, both contacts are listed for investor and media relations.